Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma

Lung Cancer

Volumn 81, Issue 3, 2013, Pages 319-327

  Cao, Christopher ^a,b,c   Tian, David H ^a   Pataky, Kristopher A ^a   Yan, Tristan D ^a,d  

^a The Collaborative Research   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c Baird Institute for Applied Heart and Lung Surgical Research   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Mesothelioma; Pleurectomy; Systematic review

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; MITOMYCIN; PACLITAXEL; PEMETREXED; PLATINUM;

ARTICLE; CANCER SURGERY; COUGHING; DATA EXTRACTION; DISEASE FREE SURVIVAL; DYSPNEA; FOLLOW UP; HUMAN; IMMUNOTHERAPY; LUNG RESECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PATIENT SELECTION; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PHOTODYNAMIC THERAPY; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL STATUS; SYSTEMATIC REVIEW;

MESOTHELIOMA; PLEURECTOMY; SYSTEMATIC REVIEW;

COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; QUALITY OF LIFE; RECURRENCE; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84881665322     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.04.024     Document Type: Article

References (41)

1. Cao C., Tian D., Manganas C., Matthews P., Yan T.D. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg 2012, 1:428-437.
2. Rusch V. Video-atlas of extrapleural pneumonectomy. Ann Cardiothorac Surg 2012, 1:532.
3. Butchart E.G., Ashcroft T., Barnsley W.C., Holden M.P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976, 31:15-24.
4. Cao C.Q., Yan T.D., Bannon P.G., McCaughan B.C. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 2010, 5:1692-1703.
5. Rice D., Rusch V., Pass H., Asamura H., Nakano T., Edwards J., et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung Cancer International Staging Committee and the International Mesothelioma Interest Group. J Thorac Oncol 2011, 6:1304-1312.
6. Lang-Lazdunski L., Bille A., Lal R., Cane P., McLean E., Landau D., et al. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 2012, 7:737-743.
7. Friedberg J. Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma. Ann Cardiothorac Surg 2012, 1:472-480.
8. Rosenzweig K.E., Zauderer M.G., Laser B., Krug L.M., Yorke E., Sima C.S., et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2012, 83:1278-1283.
9. Nakas A., von Meyenfeldt E., Lau K., Muller S., Waller D. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma. Eur J Cardiothorac Surg 2012, 41:1031-1036.
10. Rena O., Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer 2012, 77:151-155.
11. Bolukbas S., Manegold C., Eberlein M., Bergmann T., Fisseler-Eckhoff A., Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 2011, 71:75-81.
12. Flores R.M., Pass H.I., Seshan V.E., Dycoco J., Zakowski M., Carbone M., et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008, 135:620-626.
13. Okada M., Mimura T., Ohbayashi C., Sakuma T., Soejima T., Tsubota N. Institutional report - thoracic general. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg 2008, 7:102-106.
14. Richards W.G., Zellos L., Bueno R., Jaklitsch M.T., Janne P.A., Chirieac L.R., et al. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006, 24:1561-1567.
15. Lee T.T., Everett D.L., Shu H.K., Jahan T.M., Roach M., Speight J.L., et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002, 124:1183-1189.
16. Rusch V.W., Venkatraman E.S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999, 68:1799-1804.
17. Colleoni M., Sartori F., Calabro F., Nelli P., Vicario G., Sgarbossa G., et al. Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori 1996, 82:53-56.
18. Luckraz H., Rahman M., Patel N., Szafranek A., Gibbs A.R., Butchart E.G. Three decades of experience in the surgical multi-modality management of pleural mesothelioma. Eur J Cardiothorac Surg 2010, 37:552-556.
19. Lucchi M., Picchi A., Alì G., Chella A., Guglielmi G., Cristaudo A., et al. Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?. Interact Cardiovasc Thorac Surg 2010, 10:572-576.
20. Nakas A., Martin Ucar A.E., Edwards J.G., Waller D.A. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008, 33:83-88.
21. Colaut F., Toniolo L., Vicario G., Scapinello A., Visentin C., Manente P., et al. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma. Chir Ital 2004, 56:781-786.
22. Lampl L., Jakob R. How should we treat malignant pleural mesothelioma (MPM)?. Acta Chir Hung 1999, 38:87-90.
23. Pass H.I., Kranda K., Temeck B.K., Feuerstein I., Steinberg S.M. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol 1997, 4:215-222.
24. Soysal O., Karaoglanoglu N., Demiracan S., Topcu S., Tastepe I., Kaya S., et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 1997, 11:210-213.
25. Lee J.D., Perez S., Wang H.J., Figlin R.A., Holmes E.C. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol 1995, 60:262-267.
26. Yan T.D., Cao C.Q., Boyer M., Tin M.M., Kennedy C., McLean J., et al. Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience. Ann Thorac Cardiovasc Surg 2011, 17:243-249.
27. Mineo T.C., Ambrogi V., Cufari M.E., Pompeo E. May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?. Eur J Cardiothorac Surg 2010, 38:245-252.
28. Schipper P.H., Nichols F.C., Thomse K.M., Deschamps C., Cassivi S.D., Allen M.S., et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 2008, 85:257-264. [discussion 264].
29. Neragi-Miandoab S., Richards W.G., Sugarbaker D.J. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Int J Surg 2008, 6:293-297.
30. Halstead J.C., Lim E., Venkateswaran R.M., Charman S.C., Goddard M., Ritchie A.J. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 2005, 31:314-320.
31. de Vries W.J., Long M.A. Treatment of mesothelioma in Bloemfontein, South Africa. Eur J Cardiothorac Surg 2003, 24:434-440.
32. Phillips P.G., Asimakopoulos G., Maiwand M.O. Malignant pleural mesothelioma: outcome of limited surgical management. Interact Cardiovasc Thorac Surg 2003, 2:30-34.
33. Aziz T., Jilaihawi A., Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002, 22:298-305.
34. Martin-Ucar A.E., Edwards J.G., Rengajaran A., Muller S., Waller D.A. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg 2001, 20:1117-1121.
35. Ceresoli G.L., Locati L.D., Ferreri A.J., Cozzarini C., Passoni P., Melloni G., et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001, 34:279-287.
36. Hastürk S., Tastepe I., Ünlü M., Çetin G., Baris Y.I. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients. J Chemother 1996, 8:159-164.
37. Sauter E.R., Langer C., Coia L.R., Goldberg M., Keller S.M. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 1995, 60:100-105.
38. Allen K.B., Faber L.P., Warren W.H. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 1994, 4:113-126.
39. Ruffie P., Feld R., Minkin S., Cormier Y., Boutan-Laroze A., Ginsberg R., et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989, 7:1157-1168.
40. Martini N., Bains M.S., Beattie E.J. Indications for pleurectomy in malignant effusion. Cancer 1975, 35:734-738.
41. Treasure T., Waller D., Tan C., Entwisle J., O'Brien M., O'Byrne K., et al. The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility study. J Thorac Oncol 2009, 4:1254-1258.